Who backs Bambusa Therapeutics?
11 investors| Investor | Type |
|---|---|
| RA Capital Management | Asset manager |
| The Invus Group | PE / buyout |
| INCE Capital | Venture capital |
| Redmile Group | PE / buyout |
| Salvia (Holzkirchen) | Family office |
| ADAR1 Capital Management | Hedge fund |
| Athos (Family Office) | — |
| BVF Partners | — |
| Dawn Biopharma | — |
| Janus Henderson Investors | — |
| + 1 more investors · a free account shows the complete list | |
The directory is free. Check sizes and activity — the working columns — are Pro.Unlock prospecting columns
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Bambusa Therapeutics
Create free account
No card required
For fundraisers
Work this list, don’t just read it
These 11 firms already write checks for companies like Bambusa Therapeutics in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.